Wall Street brokerages expect HealthStream, Inc. (NASDAQ:HSTM) to post $61.98 million in sales for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for HealthStream’s earnings, with the highest sales estimate coming in at $63.10 million and the lowest estimate coming in at $61.10 million. HealthStream reported sales of $58.74 million in the same quarter last year, which indicates a positive year-over-year growth rate of 5.5%. The business is expected to report its next quarterly earnings report on Tuesday, February 20th.
According to Zacks, analysts expect that HealthStream will report full-year sales of $61.98 million for the current year, with estimates ranging from $246.00 million to $248.00 million. For the next fiscal year, analysts anticipate that the business will report sales of $267.75 million per share, with estimates ranging from $263.56 million to $271.70 million. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow HealthStream.
HealthStream (NASDAQ:HSTM) last posted its quarterly earnings results on Monday, October 23rd. The technology company reported $0.08 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.05 by $0.03. The business had revenue of $63.60 million during the quarter, compared to the consensus estimate of $62.48 million. HealthStream had a net margin of 2.36% and a return on equity of 2.46%. The company’s quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.04 earnings per share.
HealthStream (NASDAQ HSTM) opened at $24.53 on Friday. The company has a market cap of $776.99, a price-to-earnings ratio of 136.29, a price-to-earnings-growth ratio of 5.14 and a beta of 0.91. HealthStream has a 12 month low of $21.81 and a 12 month high of $31.53.
Several institutional investors have recently added to or reduced their stakes in HSTM. Janus Henderson Group PLC purchased a new stake in shares of HealthStream during the 2nd quarter worth $23,186,000. Conestoga Capital Advisors LLC lifted its position in shares of HealthStream by 17.2% during the 4th quarter. Conestoga Capital Advisors LLC now owns 1,755,050 shares of the technology company’s stock worth $40,647,000 after purchasing an additional 257,400 shares during the last quarter. Emerald Mutual Fund Advisers Trust purchased a new stake in shares of HealthStream during the 3rd quarter worth $5,643,000. FMR LLC lifted its position in shares of HealthStream by 2.5% during the 2nd quarter. FMR LLC now owns 4,733,510 shares of the technology company’s stock worth $124,586,000 after purchasing an additional 116,309 shares during the last quarter. Finally, Vanguard Group Inc. lifted its position in shares of HealthStream by 4.0% during the 2nd quarter. Vanguard Group Inc. now owns 2,324,958 shares of the technology company’s stock worth $61,193,000 after purchasing an additional 89,220 shares during the last quarter. 74.48% of the stock is owned by institutional investors and hedge funds.
HealthStream, Inc (HealthStream) provides workforce, patient experience and provider solutions for healthcare organizations. The Company operates in three segments: HealthStream Workforce Solutions, HealthStream Patient Experience Solutions and HealthStream Provider Solutions. HealthStream’s products and services are organized into three segments: Workforce Solutions, Patient Experience Solutions, and Provider Solutions.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.